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Neuronal loss is a hallmark of AIDS dementia syndromes. Human immunodeficiency virus type I (HIV-1)-specific proteins may induce
neuronal apoptosis, but the signal transduction of HIV-1 gp120-induced, direct neuronal apoptosis remains unclear. Ethanol (EtOH) is
considered to be an environmental co-factor in AIDS development. However, whether EtOH abuse in patients with AIDS increases neuronal
dysfunction is still uncertain. Using pure, differentiated, and post-mitotic NT2.N-derived human neurons, we investigated the mechanisms of
HIV-1 and/or EtOH-related direct neuronal injury and the molecular interactions between HIV-1-specific proteins and EtOH. It was
demonstrated that NT2.N neurons were susceptible to HIV-1 Bal (R5-tropic strain) gp120-induced direct cell death. Of importance, EtOH
induced cell death in human neurons in a clinically-relevant dose range and EtOH strongly potentiated HIV-1 gp120-induced neuronal injury
at low and moderate concentrations. Furthermore, this potentiation of neurotoxicity could be blocked by N-methyl-d-aspartate (NMDA)
receptor subunit 2B (NR2B) antagonists. We analyzed human genomic profiles in these human neurons, using Affymetrix genomics
technology, to elucidate the apoptotic pathways involved in HIV-1- and EtOH-related neurodegeneration. Our findings indicated significant
over-expression of selected apoptosis functional genes. Significant up-regulation of TRAF5 gene expression may play an essential role in
triggering potentiation by EtOH of HIV-1 gp120-induced neuronal apoptosis at early stages of interaction. These studies suggested that two
primary apoptotic pathways, death receptor (extrinsic) and NMDA receptor (intrinsic)-related programmed cell-death pathways, are both
involved in the potentiation by EtOH of HIV-1 gp120-induced direct human neuronal death. Thus, these data suggest rationally-designed,
molecular targets for potential anti-HIV-1 neuroprotection.
D 2005 Elsevier Inc. All rights reserved.
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More than 20% of patients with AIDS develop HIV-1-
associated dementia (HAD) (McArthur et al., 1993), a
neurodegenerative syndrome characterized by cognitive and
motor dysfunction that results from damage to synapses and
death of neurons in brain regions such as the hippocampus
and basal ganglia (Ikonomidou et al., 2000). Neuronal0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.01.014
T Corresponding author. Fax: +1 215 503 2624.
E-mail address: roger.j.pomerantz@jefferson.edu (R.J. Pomerantz).apoptosis in the brain is a characteristic feature of HAD in
both pediatric and adult cases (Adle-Biassette et al., 1995;
An et al., 1996; Krajewski et al., 1997; Miller, 1999; Petito
and Roberts, 1995; Shi et al., 1996). Since neurons are not
productively infected by HIV-1, how this lentiviral infection
causes neuronal damage and apoptosis is not completely
understood (Kaul et al., 2001). Neurotoxins (e.g., glutamate,
pro-inflammatory cytokines, chemokines, nitric oxide, and
other cellular factors) activate the NMDA receptor-medi-
ated, mitochondrial-regulated, intrinsic apoptotic pathway,
which is thought to be one major pathway in vivo. HIV-1005) 59–73
W. Chen et al. / Virology 334 (2005) 59–7360indirectly injures neurons by infecting macrophages/micro-
glia with release of neurotoxins [reviewed in references
Kaul et al., 2001; Kolson et al., 1998; Lipton and Gendel-
man, 1995). Nonetheless, evidence also supports the roles of
HIV-1-specific proteins, including the HIV-1 envelope
glycoprotein gp120, Tat, and Vpr, in the induction of
neuronal injury (reviewed in Kaul et al., 2001)]. Thus, HIV-
1 proteins either activate macrophages/glia, releasing neuro-
toxins (Garden et al., 2002; Zheng et al., 1999), or directly
kill neurons (Bachis et al., 2003; Hesselgesser et al., 1998;
Xu et al., 2004).
Previous studies indicated a major role for the NMDA
receptor-mediated pathway, followed by mitochondrial
dysfunction and the Bcl-2 family-regulated intrinsic path-
way in HIV-1/monocyte-derived macrophages (MDM)-
induced neuronal apoptosis (Chen et al., 2002). We have
demonstrated that intact virions or individual free viral
proteins, such as gp120, Vpr, and Tat (Adamson et al., 1996;
Eugenin et al., 2003; Johnston et al., 2001; Kruman et al.,
1998; Nath et al., 2000; New et al., 1997; Patel et al., 2000;
Trillo-Pazos et al., 2000; Xu et al., 2004; Yeung et al.,
1998), may be somewhat more potent than soluble factors
released from infected macrophages in inducing neuro-
toxicity. These findings raise the importance of the direct
neurotoxicity of HIV-1 proteins and related mechanisms
(Xu et al., 2004).
Among the HIV-1-specific proteins studied, the viral coat
protein, gp120, manifests neurotoxic effects in both primary
human central nervous system (CNS) cell cultures (Lannu-
zel et al., 1995; Yeung et al., 1995) and transgenic mice
(Thornberry and Lazebnik, 1998). Utilizing isolated neu-
rons, HIV-1 gp120 may directly promote apoptosis (Bachis
et al., 2003; Hesselgesser et al., 1998; Meucci et al., 1998;
Patel et al., 2000; Trillo-Pazos et al., 2000; Xu et al., 2004;
Zheng et al., 1999). The CXCR4 chemokine receptor has
been thought to mediate gp120-induced neuronal death
(Hesselgesser et al., 1998; Meucci et al., 1998), and in vitro
reports showed the robustness of gp120 from X4 strains of
HIV-1 (e.g., SF2, IIIB), which use the CXCR4 class of
chemokine receptor as a cofactor for viral entry, in inducing
neuronal apoptosis. Nonetheless, considering the fact that
HIV-1 strains isolated from patients with HAD, and capable
of infecting microglia, are often M (macrophage)-tropic,
interacting with the CCR5 chemokine receptor, it was
reasonable to choose an R5 HIV-1 gp120 for our studies
(Xu et al., 2004).
Apoptosis is executed by caspases, a family of proteases
that disassemble the cell. There are two well-described
pathways for apoptosis: the death receptor or TNF receptor
super family (TNFRSF) (including TNF receptor, Fas, and
TRAIL receptor)-mediated extrinsic pathway, and the
NMDAR-mediated, mitochondrial-related intrinsic pathway
(Eldadah and Faden, 2000; Saraste and Pulkki, 2000;
Thornberry and Lazebnik, 1998). Both pathways ultimately
converge via activation of the downstream effector, caspase-
3. The extrinsic pathway is controlled by the initiatorcaspase-8, and the intrinsic pathway occurs through release
of cytochrome c from mitochondria and activation of the
initiator caspase-9. However, there exists cross-talk between
these two primary apoptotic pathways through cleavage of
Bid, another pro-apoptotic Bcl-2 family member in some
cell types (Li et al., 1998; Luo et al., 1998). Although the
NMDA receptor-mediated, mitochondrial/bcl-2-regulated
intrinsic apoptotic pathway is thought to be one major
pathway in neurodegeneration, recent reports concerning the
activation of different caspases (Garden et al., 2002; Patel et
al., 2000), as well as the gene expression of death receptor-
related apoptosis signal pathways (Xu et al., 2004), also
imply that two primary apoptotic signal pathways are
involved in HAD.
Whether EtOH serves as a cofactor in AIDS development
is uncertain (for reviews, see Dingle and Oei, 1997;
Meyerhoff, 2001). However, EtOH does exacerbate oppor-
tunistic infections in a murine AIDS-like syndrome (Alak et
al., 1993; Sepulveda et al., 2002), and opportunistic
infections are correlated with the progression of AIDS (for
a review, see Friedman et al., 2003). EtOH may result in
human neurodegeneration (Ikegami et al., 2003) and shares
a similar neuronal death signal pathway (Glut, mitochon-
dria/bcl-2, oxidative stress; for a review, see Goodlett and
Horn, 2001). In addition, nerve growth factor, transforming
growth factor-h1, insulin-like growth factor-1, and brain-
derived neurotropic factor may protect against EtOH-related
neurodegeneration (Bradley et al., 1999; Hallak et al., 2001;
Luo et al., 1997; Miller et al., 2003; Pantazis et al., 2000)
and HIV-1-related neurodegeneration (Bachis et al., 2003;
Meucci and Miller, 1996; Ying Wang et al., 2003).
Furthermore, EtOH not only potentiates HIV-1 infection
of human blood mononuclear phagocytes (Wang et al.,
2002), but as shown by our laboratories also strongly
increases HIV-1 protein-induced apoptosis in primary
human brain microvascular endothelial cells (MVEC)
(Acheampong et al., 2002). In contrast, certain data
demonstrate that EtOH has both potentiation and suppres-
sive roles in HIV-1-induced neuronal death in different cell
culture models (Belmadani et al., 2003, 2001; Collins et al.,
2000). One major reason for this may come from the glia/
neuron co-culture model, which increases the difficulties in
addressing the direct effects on neurons, although it is
possible that EtOH exists as a concentration-dependent,
btwo-edged swordQ to alter the fate of neurons exposed to
HIV-1 (Belmadani et al., 2003).
The NT2.N human neuron is a well-established model
for HIV-1 neurodegeneration research, including HIV-1-
infected macrophages and HIV-1-specific viral proteins
(Chen et al., 2002; Hesselgesser et al., 1998; Patel et al.,
2000; Pomerantz, 2004; Wu et al., 1996; Xu et al., 2004; Yi
et al., 2003), as well as for other non-viral neurodegener-
ative diseases. Using pure, post-mitotic, and fully differ-
entiated NT2.N human neurons, we investigated the
molecular mechanisms of HIV-1 and/or EtOH-related direct
neuronal injury. We also tested our hypotheses that EtOH
W. Chen et al. / Virology 334 (2005) 59–73 61may potentiate HIV-1 Bal (R5) gp120-induced neuronal
damage and that this potentiation may involve the death
receptor and/or the NMDA receptor-related primary apop-
totic signal pathways.Results
Ethanol and HIV-1 Bal gp120 induce direct neuronal injury
in NT2.N human neuron cultures, and ethanol potentiates
gp120-induced neurotoxicity
NT2.N-derived neurons are morphologically and func-
tionally similar to primary human CNS neurons and have
been extensively used as a model for studies of the
mechanisms of neuronal excitotoxicity and apoptosis
(Munir et al., 1995; Pekosz et al., 1996; Pleasure et al.,
1992; Rootwelt et al., 1998). NT2.N neurons have also been
widely used for the study of HIV-1-specific proteins,
including gp120 (Hesselgesser et al., 1998; Xu et al.,
2004) and Vpr (Patel et al., 2000) related neuronal damage
in pure NT2.N neuron cultures, and for the studies of HIV-Fig. 1. Neuronal apoptosis induced by ethanol can be demonstrated and quantifie
neurons were cultured on PDL- and Matrigel-coated chambers, exposed to EtOH a
Hoechst 33342 (panel B) and propidium iodide (PI) (panel C) staining, as described
similar apoptotic neuron percentages using two different assays. Panel A demonstr
microscopy. Apoptotic neurons showed both PI-positive and condensed and bright
a representative study of three independent experiments.1-infected macrophage-related neurodegeneration in NT2.N
neuron/astrocyte mixed co-cultures (Chen et al., 2002). Of
note, until the present studies, this model had not been
utilized in studying EtOH-related neurodegeneration.
To determine whether EtOH could directly induce
NT2.N neurotoxicity, we treated NT2.N neurons with a
molecular biological grade EtOH standard. After
24 h, as shown previously to be a peak for HIV-1-induced
neuronal apoptosis (Patel et al., 2000; Xu et al., 2004), the
supernatants were collected for neurotoxicity determinations
by LDH assays. NT2.N neuron cultures were examined by
PI and Hoechst staining for apoptotic neurons. As a positive
control, we exposed the cultures to FasL or glutamate
(Giulian et al., 1993; Lipton et al., 1991; Rootwelt et al.,
1998). We found there existed a dose-dependent response
both in cell death and in apoptosis at the clinically relevant
concentration range of EtOH from 16.7 to 83 mM. Fig. 1
illustrates the pure, differentiated post-mitotic NT2.N
neurons that were treated with EtOH (16.7 mM), and then
were assessed for apoptosis using Hoechst 33342 (Fig. 1B)
and propidium iodide (PI) staining (Fig. 1C). Fig. 1A
demonstrates neurons under light microscopy and Fig. 1Dd in pure NT2.N human neuron cultures. Pure, fully differentiated NT2.N
t a concentration of 16.7 mM for 24 h, and then examined for apoptosis by
in Materials and methods. Panel D shows a Hoechst/PI overlay, suggesting
ates the morphology of the same neuron cultures under phase-contrast light
apoptotic nuclei by Hoechst staining. Magnification (A–D) = 200. This is
W. Chen et al. / Virology 334 (2005) 59–7362illustrates a Hoechst/PI overlay. Apoptotic neurons demon-
strated both PI-positive and condensed plus bright apoptotic
nuclei in Hoechst staining (i.e., greater than 95% positive
cells were double positive), consistent with previous reports
using rat primary hippocampal cultures (Belmadani et al.,
2003; Moulder et al., 2002). As such, based on these initial
studies, pure cultures of NT2.N neurons were felt to be a
useful model for EtOH-induced direct neurotoxicity.
The robust neurotoxicity of gp120 is thought to be due to
a combination of glutamate receptor activation, [Ca2C]i
elevations, and/or oxidative stress, but pro-inflammatory
cytokine mechanisms might also be involved (Bezzi et al.,
2001; Kaul et al., 2001). At least in higher concentrations,
gp120 may directly augment NMDA receptor responses via
binding to the glycine coagonist site (Gemignani et al.,
2000; Pattarini et al., 1998). Belmadani et al. (2003)
reported that co-exposure of gp120 with 30 mM EtOH
prevents neurotoxicity induced by gp120 in rat organotypic
brain slice cultures. However, coexposure of gp120 with
100 mM EtOH potentiated neuronal death, as compared to
gp120 alone. We analyzed different doses of EtOH,
including low, moderate, and high doses, to try to elucidate
the clear effects of EtOH on gp120-induced neurotoxicity
using pure NT2.N neuron cultures. We utilized two
complementary assays for neuronal death; total LDH release
as a measure of total neuronal death and the Hoechst/PI
assay to measure programmed cell death. We chose to use
recombinant HIV-1 gp120 from a macrophage-tropic (R5)
Bal strain of the virus at a relatively low concentration (Xu
et al., 2004) not only because this gp120 is purified from a
mammalian cell expression system allowing appropriate
post-translational modifications and preventing contamina-
tion with bacterial proteins, but also because M-tropic (R5)
strains of HIV-1 seem to possess a strong connection with
HAD and are capable of infecting microglia and macro-
phages. We recently reported a dose-dependent increase in
NT2.N neuronal cell apoptosis using a macrophage-tropic
(R5) HIV-1 Bal envelope surface glycoprotein, gp120
(Xu et al., 2004).
Our present results demonstrate that there exists a dose-
dependent response for total cell death, as measured by total
LDH release, at the clinically relevant concentration range
of EtOH from 16.7 to 83 mM (Fig. 2A). Interestingly, EtOH
at the same doses of 16.7 and 50 mM failed to potentiate
another HIV-1-specific viral protein, namely Tat-induced
total neuronal death by LDH release (Fig. 2A). EtOH at
moderate clinical doses of 16.7 and 50 mM, but not a high
dose of 83 mM, potentiated gp120 Bal-induced neuronal
apoptosis (concentration of 100 ng/ml equivalent to 830
pM), as measured by Hoechst/PI staining (Fig. 2B).
Surprisingly, we found that EtOH at a low dose of 8.3
mM more significantly potentiated gp120-induced apoptosis
(3.5-fold) than with a moderate dose of 16.7 mM (2-fold)
and as compared to gp120 alone (0.5-fold) (Fig. 2B). No
potentiation of gp120-induced apoptosis by EtOH at a high
dose of 83 mM was demonstrated, and the level of apoptosiswas similar to EtOH-induced apoptosis alone at 83 mM
(Fig. 2B). These data suggest that human neurons are more
susceptible to low doses of EtOH combined with gp120 and
also suggest that apoptosis is a more sensitive determination
in neurons than total cell death.
The NMDA receptor NR2B mediates HIV-1 gp120,
EtOH, and gp120/EtOH-induced direct cell-death in
NT2.N neurons
The NT2.N neuron model has been confirmed to show
similar pathways of HIV-1/macrophage-induced apoptosis
mediated by the NMDA receptor as identified in primary
neurons (Chen et al., 2002); for NT2.N neurons express
functional NMDA-type glutamate receptors, which mediate
excitotoxic cell death in response to cognate ligands (Itoh et
al., 1998; Munir et al., 1995; Rootwelt et al., 1998).
Activation of NMDA receptors is well-described in indirect
neuronal cell death induced by gp120 (Giulian et al., 1993;
Lipton et al., 1991), as well as neuronal death induced by
HIV-1-infected macrophage culture supernatants, showing
inhibition of cell death by specific NMDA glutamate
receptor antagonists (Giulian et al., 1993, 1996). Never-
theless for gp120-related direct neuronal injury, CXCR4 has
been implicated in mediating a death pathway (Bachis et al.,
2003; Hesselgesser et al., 1998). EtOH-induced neuronal
death also connects to NMDA glutamate receptor activation
(Chandler et al., 1993; Crews et al., 1998; Hansen et al.,
1997; Liesi, 1997).
To determine whether potentiation by EtOH of gp120-
induced total neuronal death is mediated by NMDA receptor
activation, we blocked NT2.N neurons with different
NMDA receptor-specific antagonists prior to HIV-1 gp120
or/and EtOH treatment. We found that the non-competitive
NMDA channel blocker, MK801, the competitive NMDA
receptor antagonist, D-AP5, and the NMDA receptor
subunit 2B (NR2B)-specific antagonist, Ifenprodil, inhibited
gp120-, EtOH-, and gp120/EtOH-induced neurotoxicity in
NT2.N neurons (Fig. 3). Of note, strongly positive control
cultures, stimulated with glutamate or FasL, were used in
initial studies (not illustrated). In addition, the nitric oxide
synthase inhibitor L-NAME also inhibited total neuronal
death induced by gp120, EtOH, and gp120/EtOH. Of note,
we illustrate total neuronal death, as the NMDA pathway
may induce apoptosis and non-apoptotic death pathways. As
such, NR2B plays an essential role in mediating both gp120
and EtOH-induced neurotoxicity.
The death receptor-related apoptotic pathway involves
potentiation by EtOH of HIV-1 gp120-induced neurotoxicity
in gene expression profiles using Affymetrix
GeneChip arrays
To define the host apoptosis genes involved in neuro-
toxicity induced by gp120 alone, EtOH alone, and the
combination of gp120 and EtOH, and to better understand
Fig. 2. Ethanol potentiates HIV-1 gp120-induced neurotoxicity. Pure NT2.N neuron cultures were exposed to different concentrations of EtOH and/or
recombinant HIV-1 Bal gp120 for 24 h, followed by analyses of apoptosis (via Hoechst/PI assays) and total cell-death (LDH release assays). Panel A shows
the total neuronal death induced by gp120 (100 ng/ml) and Tat (100 ng/ml), with and without EtOH (by LDH release). EtOH induced total neuronal cell
death in a dose-dependent manner, and EtOH synergistically potentiated gp120-induced neurotoxicity with EtOH treatments of 16.7 and 50 mM, but EtOH
did not potentiate Tat-induced cell-death (utilizing a relatively low concentration of gp120: 830 pM = 100 ng/ml). Panel B demonstrates that EtOH strongly
and synergistically enhanced gp120-induced neuronal apoptosis (by Hoechst/PI staining) at low (8.3 mM) and moderate EtOH concentrations (16.7 mM).
Negative controls received heat-inactivated viral protein. These results are expressed as the mean percentage of neurotoxicity from two independent
experiments F SEM.
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apoptosis at a genomics level, we utilized targeted
Affymetrix GeneChip array analysis. Total RNA from
control and treatment groups was prepared 24 h after
treatment and subjected to microarray hybridization with
the Affymetrix GeneChip Human Genome U133 Plus 2.0
Array (HG-U133 Plus 2.0) microarrays, which contain
1,300,000 unique oligonucleotide features covering over
47,000 transcripts and variants which, in turn, represent
approximately 39,000 of the best characterized human
genes. In addition, there are 9921 new probe sets
representing approximately 6500 new genes. The majorityof the probe sets used in the design of the array were
selected from GenBank, dbEST, and RefSeq.
Based on our stringent criteria described in Materials and
methods, among 1,300,000 qualifiers on the HG-U133 Plus
2.0 chip, we found 108 up-regulated genes in the gp120 Bal
treatment group; 53 up-regulated genes and one down-
regulated gene in the EtOH treatment group; and 34 up-
regulated genes and one down-regulated gene in the
combined gp120 Bal and EtOH treatment group, versus
the control group. Functional classification of these genes
was performed using the Gene Ontology Mining Tool and
literature searches.
Fig. 3. NMDA receptor antagonists inhibit the potentiation by ethanol in HIV-1 gp120-induced neurotoxicity. Neuronal cultures were pre-incubated with
various NMDA receptor antagonists prior to exposure to EtOH (16.7 mM) and/or HIV-1 Bal gp120 (830 pM), and examined by LDH release assays 24 h later.
Individual cultures were pre-incubated with the antagonists as follows: MK801 (10 AM), D-AP5 (1 mM), Ifenprodil (10 AM), and L-NAME (100 AM).
NMDAR antagonists significantly blocked HIV-1 gp120- and EtOH-induced neurotoxicity and inhibited the statistically significant potentiation by EtOH of
HIV-1 gp120-induced neurotoxicity. These data represent an average of three independent experiments. The results are expressed as the mean F SEM.
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number of signaling candidates. At present, we have
focused on connections between the different pathways
implicated in apoptosis. Our data demonstrated apoptosis
and apoptosis-related stress/inflammation/defense response-
related genes up-regulated in response to gp120-, EtOH-,
and gp120/EtOH-induced neuronal apoptosis.
These studies illustrate that apoptosis functional genes,
NCKAP1, CED-6 (caspase-6-like), and TNFRSF5 (CD40),
were up-regulated 8.57-, 4.59-, and 4.29-fold, respectively,
in gp120 Bal-induced apoptotic NT2.N neurons; apoptosis
functional genes, CASP1, F2R, PHLDA2, were up-regu-
lated 6.50-, 4.29-, and 4.00-fold, respectively, in EtOH-
induced apoptotic NT2.N neurons; and apoptosis functional
genes, TRAF5, CASP1, NALP1, were up-regulated 11.31-,
6.50-, and 4.59-fold, respectively, in gp120 Bal/EtOH-Table 1
Up-regulation of apoptosis genes by HIV-1 gp120, ethanol, and gp120/ethanol in
Gene
NCK-associated protein 1
PTB domain adaptor protein CED-6
Tumor necrosis factor receptor superfamily, member 5
Caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase)
Coagulation factor II (thrombin) receptor
Pleckstrin homology-like domain, family A, member 2
TNF receptor-associated factor 5
Caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase)
NACHT, leucine rich repeat and PYD containing 1induced apoptotic NT2.N neurons. These new apoptotic
candidates in death receptor-mediated death pathways, all
quite significantly up-regulated, may play essential roles in
triggering neuronal apoptosis at early stages in HIV-1
gp120-, EtOH-, and gp120/EtOH-induced neuronal apopto-
sis. Meanwhile, other up-regulated genes involving gluta-
mate receptor activation, oxidative stress, and other stress
pathways also suggest NMDA receptor/mitochondria-
related signal pathways may be active in these complex
neurodegeneration events (Table 1).Discussion
In this study, we analyzed EtOH- and HIV-1 gp120-
induced direct neuronal injury and the interactions betweenhuman NT2.N-derived neurons, using Affymetrix GeneChip array assays
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established NT2.N human neuron model system, which
like most neurons are CD4 negative (Patel et al., 2000). We
demonstrated that gp120 of the R5 strain of HIV-1, Bal,
induced direct death in these NT2.N neurons. The binding
properties of R5-tropic gp120s to human neurons still
require further study. Of importance, we found that EtOH
induced direct cell death in human neurons at a clinically-
relevant dose range and demonstrated that EtOH strongly
potentiated HIV-1 gp120-induced neuronal apoptosis at low
and moderate concentrations. Furthermore, this potentiation
of neurotoxicity could be blocked by NR2B antagonists.
This is the first demonstration that NR2B mediates the
potentiation by EtOH in gp120-induced direct neuronal
damage. In addition, we analyzed gene expression profiles
involved in HIV-1- and/or EtOH-related neurodegeneration,
using Affymetrix GeneChip microarray technology, to
elucidate the early apoptotic events in neurons. Our findings
firstly indicated that TNFRSF5 and TRAF5 involved in the
TNFRSF-mediated death pathway and expression of spe-
cific genes (e.g., TRAF5, CASP1, NCKAP1) were signifi-
cantly increased in apoptotic neurons and thus may be
involved in the induction of neuronal apoptosis at early
stages. Significant up-regulation of TRAF5 gene expression
may play an essential role in triggering potentiation by
EtOH of HIV-1 gp120-induced neuronal apoptosis. Our
studies first demonstrated that NMDAR- and death receptor-
or TNFRSF-related apoptotic pathways involved potentia-
tion by EtOH in HIV-1 gp120-induced direct human
neuronal death, and further that neuroprotective strategies
against HIV-1 and EtOH-related neurodegeneration may
now be developed based on their precise signaling cascades.
Ethanol induces direct neuronal injury at
pathophysiologically relevant concentrations
Alcohol-associated neurodegeneration may involve neu-
ronal apoptosis. EtOH-induced apoptosis has been reported
in the developing rat brain (Ikonomidou et al., 2000), in the
mouse hippocampus (Pawlak et al., 2002), and in the
hippocampus and superior frontal cortex of human alco-
holics with well-characterized clinical features (Ikegami et
al., 2003). By altering glutamate and GABA transmission,
alcohol suppresses neuronal activity, causing millions of
nerve cells to commit suicide in the developing brain. These
pro-apoptotic effects of alcohol provide a likely explanation
for the diminished brain size and life-long neurobehavioral
disturbances associated with the human fetal alcohol
syndrome. Among these mechanisms are increased oxida-
tive stress, damage to the mitochondria, interference with
the activity of growth factors, effects on glia cells, impaired
development and function of chemical messenger systems
involved in neuronal communication, changes in the trans-
port and uptake of the sugar glucose, effects on cell
adhesion, and changes in the regulation of gene activity
during development (for a review, see Goodlett and Horn,2001). Recent findings showed that EtOH-induced neuro-
apoptosis is an intrinsic pathway-mediated phenomenon,
involving Bax-induced disruption of mitochondrial mem-
branes and cytochrome c release as early events leading to
caspase-3 activation (Farber and Olney, 2003; Young et al.,
2003). Our results demonstrated that EtOH induced direct
neuronal damage at pathophysiologically-relevant concen-
trations (16.7–83 mM). NR2B-mediated, EtOH-induced
neuronal damage can be blocked by the iNOS-specific
inhibitor, L-NAME, consistent with previous reports con-
cerning a mechanism involving increased oxidative stress
and the mitochondria-related intrinsic apoptosis pathway
(Farber and Olney, 2003; Young et al., 2003).
Ethanol potentiates HIV-1 gp120-induced direct neuronal
damage at low concentrations
Recent reports showed the potentiation by EtOH of HIV-
1 infection of human blood mononuclear phagocytes (Wang
et al., 2002) and induction of apoptosis by HIV-1 proteins in
primary human brain MVEC (Acheampong et al., 2002).
Belmadani et al. (2003) demonstrated that co-exposure with
HIV-1 gp120 and EtOH in rat organotypic brain slice
cultures led to curtailment of gp120-induced neurotoxicity
and neurotoxic mediators by moderate (30 mM), but not
high, EtOH concentrations (100 mM). They suggest that
EtOH’s concentration-dependent, btwo-edged swordQ
behavior could alter the development of dementia in HIV-
1-infected individuals during social EtOH consumption or
abuse (Belmadani et al., 2003). As this group used a rat
brain slice co-culture model, further studies are needed to
elucidate the differing apparently glial effects of the two
concentrations of EtOH. We utilized pure differentiated
NT2.N human neurons as a model and found that EtOH
potentiated gp120 direct neuronal injury at low and
moderate concentrations, but not at a high concentration.
This is the initial report to show the potentiation of EtOH in
gp120-induced human neuronal damage at low and moder-
ate concentrations, implicating even less quantities of
alcohol than ingested during social consumption may
augment neurodegeneration in certain patients with AIDS.
HIV-1 gp120, as an agonist of the NMDA receptor,
activates NR2B-induced direct neuronal death
Similar to EtOH, HIV-1-induced neuronal damage is also
mediated by NMDAR activation (Meucci and Miller, 1996;
Wu et al., 1996), as demonstrated in the NT2 neuronal
model (Chen et al., 2002). The mechanism(s) of how HIV-1
gp120 triggers neuronal injury is an important topic, but
there is no clear understanding of this complex phenom-
enon. Nonetheless, there are some hypotheses for interpre-
tation of the neuronal death events caused from gp120
indirect neurotoxicity via activating macrophage/microglia
to release neurotoxins, which trigger the intrinsic and/or
extrinsic death pathways. For gp120 direct neuronal injury
W. Chen et al. / Virology 334 (2005) 59–7366effects, there is no precise connection between already
known death pathways, especially for HIV-1 gp120s from
R5-tropic viral strains, although the CXCR4 chemokine co-
receptor has been thought to mediate gp120-induced
neuronal death. The gp120 in these previous reports belongs
to X4-tropic HIV-1 strains (Bachis et al., 2003; Hesselgesser
et al., 1998; Meucci et al., 1998; Zhang et al., 2003). The
NMDAR antagonist, memantine, rescued neuronal injury
induced by gp120, in cultured neurons, as well as in gp120
transgenic mouse (Lipton, 1992; Muller et al., 1992, 1996;
Nath et al., 2000; Toggas et al., 1996), suggesting the
potential role for NMDAR in gp120-related neuronal injury.
Our pure NT2.N neuronal cultures abrogated the possibility
of glutamate-like neurotoxin released from glial cells
infected by HIV-1 or activated by gp120.
Excitatory amino acid receptors are thought to be
activated only by specific amino acids. However, an
antibody to the GluR3 subunit can lead to activation of
AMPA receptors (Tschopp et al., 2003), and auto-anti-
bodies to GluR3 are strongly implicated in the disease
process leading to Rasmussen’s encephalitis (Rogers et al.,
1994). Song et al. (2003) also demonstrated that the
NMDA receptor is capable of direct activation by the HIV-
1 regulatory protein, Tat, with a molecular mass of 14
kDa. They showed a novel action of the Tat protein of
HIV-1 as an agonist of the NMDA receptor, possibly
acting at the allosteric Zn 2C-binding site. In addition,
HIV-1 gp120 binds through its V3 sequence to the glycine
site of NMDA receptors present on hippocampal terminals
of noradrenergic neurons mediating noradrenaline release
in the hippocampus (Pattarini et al., 1998) and neuro-
peptide release in cerebral neurons (Gemignani et al.,
2000).
Our results revealed NR2B-mediated HIV-1 gp120-
induced neuronal damage, demonstrating that HIV-1
gp120 acts as an agonist of the NMDA receptor and
activates NR2B-induced direct neuronal death. This finding
is also compatible with the hypothesis that these NMDA
receptors contain the triple subunit combination NR1/
NR2A/NR2B (Gemignani et al., 2000), and supports the
consideration that NMDA receptor activation and the effects
of gp120 and its V3 sequence may be relevant to the
pathology of HAD (Pattarini et al., 1998).
In addition, gp120 and Tat also cause neuronal dysfunc-
tion and death in rodents in vivo and can render neurons
vulnerable to excitotoxicity and oxidative stress via dis-
rupting neuronal calcium homeostasis. By altering voltage-
dependent calcium channels, glutamate receptor channels,
and membrane transporters, the HIV-1-specific proteins
promote calcium overload, oxygen free-radical production,
and mitochondrial dysfunction (Haughey and Mattson,
2002), also suggesting HIV-1 protein-related neurodegener-
ation involves the NMDAR-mediated, mitochondria-related
intrinsic apoptosis pathway. Our present observations may
thus have implications for future pharmacological
approaches in treating HAD and will also further ourunderstanding of the biology of HIV-1 gp120 and NMDA
receptors.
Up-regulated functional apoptosis genes in human neurons
Garden et al. (2002) demonstrated that neuronal active
caspase-3-like immunoreactivity is significantly elevated in
cerebrocortical neurons from patients with HAD, as well as
in cultured rodent neurons exposed to HIV-1 gp120.
Neurons exposed to HIV-1 gp120 undergo activation of
two upstream caspases, caspase-8 and caspase-9, and
inhibition of either pathway prevents neuronal apoptosis.
These caspase cascades involve two major apoptotic
pathways: Death receptor- and NMDA receptor-related
apoptotic pathways. Patel et al. (2000) found caspase-8
activation mediated HIV-1 Vpr-induced neuronal apoptosis,
and we recently reported death receptor-signaling is
involved in HIV-1 Bal (R5 strain) gp120-mediated neuro-
nal cell injury (Xu et al., 2004). We also reported that a
series of downstream candidates of the death receptor
(including TNF-R1 and Fas)-mediated apoptosis were up-
regulated within apoptotic neurons, suggesting that the
death receptor (TNF receptor superfamily members)-related
pathways might be engaged in neuronal apoptosis
(Xu et al., 2004).
To further elucidate molecular mechanisms involved in
the induction of apoptosis at a genomics level, we now
utilized Affymetrix GeneChip genomic analyses. Analysis
of gene expression using these arrays allows for the
simultaneous examination of the expression levels of
thousands of genes. An advantage of this methodology is
that it enables investigators to identify new and novel genes;
those that have not previously been described in a specific
experimental model or pathogenesis (Pomerantz, 2004). Our
findings showed a number of new candidates in TNFRSF-
mediated death pathway. They may play essential roles in
triggering neuronal apoptosis at early stages, for their gene
expressions were significantly up-regulated in apoptotic
neurons.
Human Nck-associated protein 1 (NCKAP1, Nap1)
belongs to a newly identified class of molecules that interact
with both the adaptor proteins (Nck) and GTPases (Rac).
Both Nck and Rac mediate growth factor-stimulated signals
by coupling cell surface receptors to downstream effector
molecules, but their signaling pathways appear different
from one another (Suzuki et al., 2000). NCKAP1 may play
an important role in the mediation of cross-talk between the
signaling pathways of these molecules. NCKAP1 is a novel
apoptosis-related gene and has a possible relationship to
Alzheimer disease (Suzuki et al., 2000; Yamamoto and
Behl, 2001; Yamamoto et al., 2001). Antisense oligo DNAs
of human NCKAP1 transcripts were found to induce
apoptosis of human neuroblastoma cells in sporadic
Alzheimer disease (Suzuki et al., 2000). Using pure, fully
differentiated and post-mitotic NT2.N human neurons, our
results showed that NCKAP1 was 8.57-fold up-regulated in
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apoptosis gene in HIV-1 neuronal degeneration.
The rapid engulfment (phagocytosis) of cells undergoing
apoptosis is a fundamental biological process. CED-6 is
adaptor molecule acting in a signal transduction pathway
that specifically mediates the recognition and engulfment of
apoptotic cells in C. elegans (Liu and Hengartner, 1998).
Human CED-6 (hCED-6) encodes a functional human
homologue of the C. elegans engulfment protein CED-6
and is a part of a highly conserved pathway that specifically
promotes phagocytosis of apoptotic cells (Liu and Hengart-
ner, 1999; Smits et al., 1999). The present studies
demonstrated that CED-6 was up-regulated 4.59-fold in
the HIV-1 gp120-treated group, also suggesting the potential
importance of the engulfment of apoptotic neurons, possibly
via interactions with macrophages and microglia.
NAcht leucine-rich-repeat protein 1 (NALP1) contains a
putative nucleotide binding site, a region of leucine-rich
repeats, and death domain folds at both termini providing
protein/protein association functions, such as caspase
recruitment (Martinon et al., 2001). Recently, NALP1 was
shown to be a component of the binflammasomeQ, mini-
mally comprised of caspase-1, caspase-5, the ASC adaptor
protein, and NALP1, and found to function in the generation
of the inflammatory cytokine interleukin-1 (Martinon et al.,
2002; Turgeon et al., 1999). Liu et al. (2004) report that
NALP1 gene expression in primary cerebellar granule
neurons stimulates apoptosis. NALP1 has also been shown
to interact with apoptotic caspases, such as caspase-2 and
caspase-9 (Hlaing et al., 2001), suggesting a potential
function in the regulation of the apoptotic caspases. Our
data showed that NALP1 was up-regulated 4.59-fold in the
gp120/EtOH treatment group. NALP1 and another compo-
nent of the binflammasomeQ, CASP1, and its possible
interaction with caspase-9, further implicate the NMDA
receptor-mediated, mitochondria-related death pathway
involved in this group (Zhang et al., 2003).
Caspase-1 (CASP1) plays a key role in inflammatory
pathways by processing pro-IL-1beta into the active
cytokine mature IL-1 beta. Zhang et al. (2003) provide
direct evidence that caspase-1 plays a key role in neuronal
cell death and that caspase-1 is an apical activator of the cell
death pathway in the pre-mitochondrial collapse stage.
Furthermore, Rip2/Cardiak/Rick is a stress-inducible
upstream modulator of pro-caspase-1 apoptotic activation.
Bid cleavage appears to be an important downstream
effector of caspase-1-mediated cell death. CASP1 showed
up-regulation (6.5-fold) in both EtOH and gp120/EtOH
groups in the present study, suggesting that other candi-
date(s) plays potentiation roles in apoptosis and that the
NMDAR-mediated death pathway is involved in both
treatment groups.
Activation of the protease-activated thrombin receptor,
(PAR)-1, induces motor neuron degeneration in the deve-
loping avian embryo (Turgeon et al., 1999). Motor neuron
cell death in wobbler mutant mice follows over-expressionof the G-protein-coupled, protease-activated receptor for
thrombin (Festoff et al., 2000). A synthetic thrombin
receptor signaling inhibitor, recombinant thrombomodulin
and E5510, may inhibit thrombin-induced neuronal cell
death (Sarker et al., 1999). Our results demonstrated
that EtOH-related neurodegeneration might connect with
thrombin.
TNF/TNFR SFPs as mediators of cell death
The capacity to induce cell death is one of the unique
properties with great adaptive value which TNF/TNFR
SFPs have evolved. Among the eight homologous death
receptors (DRs) in the TNFR superfamily, at least six can
stimulate apoptosis through activation of caspases. Other
TNF/TNFR SFPs that lack death domains can potently
modulate the response to DRs or directly influence cell
survival (for a review, see Locksley et al., 2001). For
example, CD40 can augment Fas-mediated B cell apoptosis
(Garrone et al., 1995). CD40 is expressed and is functional
on neuronal cells in both adult murine and human brains
(Tan et al., 2002).
The tumor necrosis factor receptor superfamily includes
12 members, some of which (e.g., TNFR I and FAS) induce
cell death triggered by ligand binding. Another member of
the superfamily, the neurotrophin receptor, p75NTR, indu-
ces neural apoptosis, with apoptosis being inhibited by
binding of the ligand to the receptor (Rabizadeh and
Bredesen, 1994). Ruan et al. (1997) showed that CD40
also induces neural apoptosis, but apoptosis is inhibited by
binding of the G28-5 monoclonal antibody to CD40. These
results provide further support for a model in which some
members of the tumor necrosis factor receptor superfamily
induce apoptosis triggered by ligand binding, whereas other
members may, at least under certain conditions, induce
apoptosis in the absence of ligand binding, with apoptosis
being inhibited by binding of ligand or monoclonal
antibody.
Our results showed, in the gp120 treatment group, that
apoptosis functional genes NCKAP1, CED-6, and
TNFRSF5 (CD40) were significantly up-regulated. CD40
was up-regulated 4.29-fold and this therefore suggested that
CD40 may share similar effects to those described in other
reports. HIV-1-specific proteins induce CD40 expression
(Henderson et al., 2004). Functional CD40 is not only
expressed on neuronal cells in human brain (Tan et al.,
2002), but also induces neuronal apoptosis (Ruan et al.,
1997). This moiety, as well as Fas/FasL, may be involved in
HIV-1-associated human neuronal damage (Xu et al., 2004).
Since CD40 and Fas belong to the TNFR superfamily and
share the common apoptosis pathway, it is reasonable to
suggest that CD40 can augment Fas-mediated neuronal
apoptosis, just as it mediates apoptosis in B cells (Garrone et
al., 1995). CD40 binds with TRAF2, 3, 5, 6 in the
cytoplasmic tail of cysteine-rich domains (Locksley et al.,
2001), and TRAF5 is involved in CD40- and CD27-
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Therefore, as in monocytes (Pearson et al., 2001), CD40
may up-regulate TRAF mRNAs and lead to activation of
mitogen-activated protein kinase signaling pathways in
human neurons. TRAF5 was up-regulated 11.31-fold in
the gp120/EtOH treatment group, and thus CD40-TRAF5 is
a convincing candidate to trigger potentiation by EtOH of
gp120-induced neuronal apoptosis.
According to our analyses of gene expression profiles at
the genomics level, we hypothesize that TNFRSF5 (CD40)
may significantly up-regulate TRAF5 gene expression to
trigger the potentiation by EtOH in gp120-induced direct
neuronal apoptosis. Taken together, our studies suggest that
two primary apoptotic pathways, Death receptor or
TNFRSF (extrinsic) and NMDA receptor (intrinsic)-related
mechanisms, are both involved in the potentiation by EtOH
of HIV-1 gp120-induced direct human neuronal death. Of
note, mechanistic differences in neuronal death induction
may be present in gp120 alone, EtOH alone, and EtOH plus
gp120 treatments.
The link between death receptor- or TNFRSF and
NMDA receptor-mediated apoptosis pathways, and the role
of other specific functional gene products, must be further
dissected. Understanding the potential mechanisms of
neuronal death caused by HIV-1-specific proteins and/or
alcohol may offer clear therapeutic targets for rational
design of neuroprotective strategies to reduce the risk of
HIV-1-related neurodegeneration.Materials and methods
Cell cultures
Undifferentiated human teratocarcinoma cells NTera
2/c1.D1 (NT-2) (Pleasure et al., 1992) were fully differ-
entiated, as described previously (Chen et al., 2002). Briefly,
2.7  106 cells were seeded in 75 cm2 flasks and exposed to
10 AM retinoic acid for 5 weeks. The cells were then replated
onto nine tissue culture dishes (10 cm), and 7 days later the
neurons were trypsin-separated from non-neuronal back-
ground cells and mechanically dispersed into a single cell
suspension for final replating. For use in GeneChip micro-
array experiments, neurons were replated onto plastic wells
coated with Matrigel (Collaborative Biomedical Products,
Bedford, MA) in DMEM with 10% fetal bovine serum,
penicillin (100 U/ml) and streptomycin (100 U/ml), 1 AM
cytosine arabinoside, 10 AM fluorodeoxyuridine, and 10 AM
uridine (Sigma). For neurotoxicity assays, the neurons were
plated onto glass chamber slides coated with Poly-d-lysine
and Matrigel, as described previously (Hesselgesser et al.,
1998). Pure neuron cultures were maintained for up to 1 week
before use. After the addition of gp120 or other compounds,
cultures were kept in the same medium until neurotoxicity
was analyzed. Control cultures that received medium
containing heat-inactivated gp120 were also utilized.HIV-1-specific proteins
The recombinant HIV-1 gp120 Bal and Tat proteins were
obtained from the NIH AIDS Research and Reference
Reagent Program. HIV-1 gp120 Bal (catalog number: 4961)
was prepared from HEK293 cells and was purified by
immunoaffinity chromatography using a monoclonal anti-
body specific for a confirmational epitope of gp120. HIV-1
Tat (catalog number: 2222) was produced in E. coli using
the Tat-expressing plasmid provided by the Glaxo Institute
for Molecular Biology, Switzerland.
Neurotoxicity
Neurons were cultured on Poly-d-lysine- and Matrigel-
coated chamber slides at a density of 2  105 cells/cm2.
After up to 7 days, HIV-1-specific viral proteins were added
to neurons. Control groups were exposed to either plain
medium or heat-inactivated HIV-1-specific proteins, plus
FasL or glutamate as positive controls. Twenty-four hours
after treatment [of note, the time-period was based on
previous studies and pilot experiments showing maximum
death and minimum background (not illustrated)], super-
natants were collected and cultures were fixed in 3.7%
formaldehyde and subjected to neurotoxicity assays, includ-
ing the neuronal death and neuronal apoptosis assays
indicated below.
Total neuronal death was measured by the release of
cytosolic lactate dehydrogenase (LDH) by dead and dying
cells using a CytoTox 96 nonradioactive cytotoxicity assay
kit (Promega, Madison, WI), according to instructions of the
manufacturer. Values were expressed as a percentage of the
total LDH release.
Neuronal apoptosis was determined by Hoechst 33342/
propidium iodide (PI) staining. Cultures were incubated
simultaneously with 2.5 Ag/ml Hoechst 33342 (staining
apoptotic and healthy cells) and 5 Ag/ml propidium iodide
(staining apoptotic cells) (both from Calbiochem, San
Diego, CA) (Hoechst/PI) for 30 min at 37 8C. For Hoechst
staining, uniformly stained nuclei were scored as healthy,
viable neurons. Condensed or fragmented nuclei were
scored as apoptotic.
Neurotoxicity was normalized as net increase (%) against
the control group, which was set as a baseline. Results
represent the mean F SEM of the two to three chambers per
treatment condition from at least two representative experi-
ments. The experiments were repeated independently at
least two to three times.
To obtain unbiased counting, the slides and chambers
were coded five pre-determined fields surrounding the
center point of the chamber were chosen by a blinded
examiner and then digitally photographed under fluores-
cence microscopy with an Olympus BX60 microscope and
Fluorescence Attachment BX-FLA. Both Hoechst-positive
and PI-positive neurons were counted utilizing Scion Image
software (version 1.62c; Scion Corp., Frederick, MD). For
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bers from two or more independent experiments were
counted, and the average percent of Hoechst/PI-positive
neurons F SEM was determined. More than 1000 neurons
were scored for Hoechst/PI reactivity on each chamber.
Blockade of neuronal damage with NMDA glutamate
receptor antagonists
To assess the role of glutamate receptors in mediating
neuronal apoptosis, NT2.N cultures were pre-treated (90
min) with the non-competitive NMDA glutamate receptor
antagonist MK-801, the competitive antagonist D-AP5,
NMDA receptor subunit 2B (NR2B)-specific antagonist
Ifenprodil, and the nitric oxide synthase inhibitor NG-nitro-
l-arginine methyl ester HCL (L-NAME) (above reagents
from Tocris Cookson Inc., Ellisville, MO), or left untreated,
before application of HIV-1 gp120, EtOH, or gp120 plus
EtOH.
Statistical analysis
The data were expressed as the mean F SEM.
Comparisons between experimental groups were performed
with a Student’s t test. Differences were considered statisti-
cally significant for P values less than 0.05.
RNA preparation and Affymetrix microarray hybridization
Affymetrix microarray analyses were performed using a
standard protocol [Affymetrix GeneChip Manual] in our
genomics core laboratory. In brief, total RNA was extracted
from the cultures of NT2.N-differentiated human neurons
using RNeasy Mini Kit (Qiagen), following the manufac-
turer’s protocols. Seven micrograms of total RNA was used
to synthesize double-stranded cDNA, with a SuperScript kit
(Invitrogen), incorporating a T7-Oligo(dT)24 promoter
primer (Affymetrix). Biotin-labeled cRNA was synthesized
from the cDNA using an Enzo BioArray HighYield RNA
Transcript Labeling Kit (Affymetrix) and purified with a
GeneChip Sample Cleanup Module (Affymetrix). These
procedures generated high-quality RNA and cRNA probes,
as shown by agarose gel electrophoresis (ratio of 28S to 18S
RNA, broad range of sizes of cRNA probes) and an
approximately equal ratio of 5V and 3V ends of arrayed
genes detected by the cRNA probes.
Eighteen micrograms of cRNA was fragmented by
heating at 94 8C for 35 min in fragmentation buffer [40
mM Tris-acetate (pH 8.1), 125 mM KOAc, 30 mM
MgOAc] prior to hybridization. Fifteen micrograms of
fragmented cRNA was hybridized to an Affymetrix Gen-
eChip HG-U133 Plus 2.0 Array using the GeneChip
Eukaryotic Hybridization Control Kit (Affymetrix), after
the probe was hybridized to a Test3 test chip to assess the
quality of the cRNA probes. All of the probes had
approximately equal representation of the 5V and 3V ends,which attests to the high quality of RNA isolated from the
NT2.N human neurons. Hybridizations were performed at
45 8C for 16 h within a GeneChip 640 hybridization oven.
Arrays were then washed and stained with phycoerythrin-
conjugated streptavidin (Molecular Probes, Eugene, OR),
and hybridization signals were amplified using antibody
amplification with goat IgG (Sigma-Aldrich) and anti-
streptavidin biotinylated antibody (Vector Laboratories,
Burlingame, CA), using the Affymetrix Fluidics Station
400, as described in the Affymetrix GeneChip Expression
Analysis Manual. Images were scanned using a GeneChip
scanner 3000 (Agilent Technologies, Palo Alto, CA),
according to Affymetrix protocols. To assess sample quality,
test hybridizations were performed using Test3 chips. All
hybridizations met or exceeded the manufacturer’s quality
control standards. Our quality control design reduced
process variability by its redundancy (e.g., at least two
replicates), ensuring consistency for correlation coefficient,
change of detection call, and rate of false change call.
Affymetrix data analysis
Data were analyzed with the Affymetrix GeneChip
Operating Software (GCOS) and Affymetrix Data Mining
Tool 2.0. The GCOS calculates detection P value using 16
pairs of perfect match (PM) and mismatch (MM) probes,
assigning each probe a present (P) or absent (A) call. Our P
values fell within b0.04 for a P call and N0.06 for an A call;
values between 0.04 and 0.06 were considered marginal.
Signal, a quantitative metric calculated for each probe set,
represents the relative expression of a transcript. Scaling, a
signal normalizing calculation, allows comparison of gene
expression levels between different gene chips; all chips
were scaled to 500. Fold change and P value measure the
signal variation of a single gene between baseline and
experimental arrays. GCOS uses Wilcoxon’s signed rank
test to calculate this variation, assigning an increase (P b
0.0025), decrease (P N 0.9975), or no change call (P
between 0.0025 and 0.9975) for each gene.
RNA isolated from individual treatment of pure, post-
mitotic, and differentiated NT2.N human neurons was
hybridized on individual chips, and each experimental
group consisted of two chips as follows:
Group 1: control;
Group 2: recombinant HIV-1 gp120 Bal (NIH AIDS
Research and Reference Reagent Program) treatment at a
concentration of 100 ng/ml for 24 h;
Group 3: EtOH standard (Molecular biological grade,
purchased from Sigma, Inc.) treatment at a concentration
of 16.7 mM for 24 h;
Group 4: gp120 Bal and EtOH treatment (at the same
concentrations and times as noted above).
The comparison data were analyzed using the Data
Mining Tool software (Affymetrix). We calculated the
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for each probe. Then the signal distribution was analyzed
with scatter plots and histograms before and after employing
a data filter. P values were calculated using both the t test
and the Mann–Whitney test. P values b0.05 were consid-
ered significant. We also defined the intersection of these
two statistical tests. Genes were considered significant if P b
0.05 for both statistical tests; signal intensity was N100; and
at least a 2-fold change in average signal intensity was
found. Gene Ontology Mining Tool (Affymetrix web site)
was used to define gene groups, according to their function
(Tang et al., 2004).Acknowledgments
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